Morgan Stanley
GCTK icon

Morgan Stanley’s GlucoTrack GCTK Stock Holding History

Morgan Stanley’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Hold
1
– – ﹤0.01% 8278
2025
Q4 		$4 Sell
1
-400
-100% -$2.37K ﹤0.01% 8163
2025
Q3 		$2.64K Buy
401
+400
+40,000% +$2.41K ﹤0.01% 7248
2025
Q2 		$6 Buy
+1
New +$9 ﹤0.01% 8040
2025
Q1 		– Sell
-1
Closed -$67 – 8040
2024
Q4 		$485 Buy
+1
New +$1.27K ﹤0.01% 7346
2024
Q3 		– Hold
0
– – – 7204

Other funds holding GCTK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Morgan Stanley's GCTK Position: Q1 2026 in Review

Morgan Stanley held its GlucoTrack (GCTK) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #8278.

Morgan Stanley first reported a position in GCTK in Q4 2024 and has held it in 5 quarters since. The position peaked at $2.64K in Q3 2025. 13 funds tracked by Wall St. Rank hold GCTK as of Q1 2026.

  • Morgan Stanley held 1 share of GlucoTrack worth $1 as of Q1 2026.
  • Morgan Stanley left its GlucoTrack share count unchanged in Q1 2026.
  • GlucoTrack made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #8278 holding.
  • Morgan Stanley first reported a position in GlucoTrack in Q4 2024 and has held it in 5 quarters since.
  • Morgan Stanley's GlucoTrack position peaked at $2.64K in Q3 2025.
  • 13 funds tracked by Wall St. Rank held GlucoTrack as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.